Second, except for PCT and hs-CRP, the joint monitoring of changes in other inflammatory indicators (e.g., IL family, TNF-α) of COPD patients can also effectively and accurately observe the disease and reduce the risk of an acute attack [31], which would be further explored in the future. This evidence concerns the gene CRP and chronic obstructive pulmonary disease.